Research & Development: Page 56
-
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Outsourcing: Adding Value to the Model
SHOWCASE FEATURE: Outsourcing: Outsourcing: Adding Value to the Model By Tarem Grom, Editor Outsourcing has become a standard worldwide business practice and management imperative and stakeholders are looking for more than cost- savings. A relatively small number of BPO clients — 20% of those par...
By Taren Grom • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Singapore a Pharma Hub for Asia
Singapore a Pharma Hub for Asia By Kim Ribbink The pharma industry is increasingly drawn to Singapore, thanks to its commitment to research and innovation, good talent base, and trusted regulatory and IP environment. Singapore is fast becoming a leading regional and even global center for the lif...
By Kim Ribbink • Jan. 28, 2014 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Rare Diseases: The Patient as Collaborator
In the rare disease market, working with patients and patient advocacy groups is critical for the success of new therapies. The voice of the patient is critical in healthcare. Nowhere is this more true than in the area of rare diseases. It’s critical to engage patients, industry experts say, to a...
By Denise Myshko • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Specialty Drugs: An Evolving Commercial Model
A changing marketplace creates new challenges and new business models for specialty medications. At the same time the industry is increasing its focus on developing specialty drugs — a projected 40% growth by 2014 and 67% by 2015, according to Express Scripts — the reimbursement, marketing, and s...
By Robin Robinson • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Last Word
Biopharmaceutical companies are becoming more fully engaged with patients as well as patient advocacy groups. Millennium’s head of patient advocacy, Tom Sellers, discusses the barriers and opportunities that early engagement entails. PV:What has precluded biopharmaceutical companies from early ...
By Tom Sellers • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Dr. Yong-Jun LIU Medimmune Names New Head of Research MedImmune, the global biologics research and development arm of AstraZeneca, has named Yong-Jun Liu, M.D., Ph.D., as the company’s new head of research. Most recently, Dr. Liu served as VP and chief scientific officer at the Baylo...
By Ann Grey • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pipelines are Shifting to Biotech Drugs Trending Now: Large molecules currently represent a dominant share of sales. The pharmaceutical industry, especially big pharma, has dramatically shifted its R&D focus from its historical concentration on small molecule drugs to include a rapidly increa...
By Denise Myshko • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
GSW Launches Multi-Channel Detailing Platform Trending Now: eDetailing allows for increased flexibility and access to physicians in a changing salesforce landscape. GSW, an inVentiv Health company and healthcare communications agency, has released iQ.mercury 3, a significant advance in pharmaceut...
By Denise Myshko • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
What's New
CAHG and Diaceutics to Launch Bioceutics Trending Now: New agency is putting the “person" back into personalized healthcare. CAHG, a global professional healthcare communications company, and Diaceutics Ltd., specialists in personalized healthcare consulting, software, and services, have launched...
By Ann Grey • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
The Fly Boy Dr. Ross Cagan’s approach to drug discovery aims to show how flies can be used to screen for new targets. The traditional process of finding a new drug starts by screening chemicals for their effect on a given target through cell-based screens. Modern drug discovery automates this, bu...
By Dr. Ross Cagan • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
UpFront
INDUSTRY at Large AbbVie Provides Grant for Math Education AbbVie has provided a a $350,000 grant for math education to the North Chicago public schools. The grant will enable educators to strengthen and reinforce the math curriculum for students (K-8) in the district and assist in the implementa...
By Denise Myshko • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Letter to the Editor
Jonah Frohlich Managing Director Manatt Health Solutions The ACA is accelerating a reorganization of the healthcare delivery system from episodic, reactive, acute management of patients, to proactive, population-based delivery models. These changes, manifest as patient centered medical homes...
By Jonah Frohlich • Jan. 27, 2014 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The State of the Industry many companies are at a crossroads, according to Cegedim Relationship management. Cegedim Relationship Management recently engaged key decision makers from leading global life-sciences enterprises to address some critical questions: how has the recent transformational pr...
By Taren Grom • Jan. 27, 2014 -
PharmaVoice Team/PharmaVoice
The Philippines: Global Pharma Appeal
With 14 of the top 20 pharma companies establishing manufacturing facilities in the Philippines, the country is clearly a go-to destination. The Philippines, an island nation in Southeast Asia, has a population of more than 95 million people, making it the 12th most populated country in the world...
By Kim Ribbink • Dec. 28, 2013 -
PharmaVoice Team/PharmaVoice
C-Suite: Clinical Services
By Taren Grom We asked C-suite executives throughout the clinical services ecosystem to provide their insights on where the biggest opportunities for innovation for improving the drug development process lie, what the biggest barriers are, and identify a recent innovation that is improving the pr...
By Taren Grom • Dec. 28, 2013 -
PharmaVoice Team/PharmaVoice
Innovation Incubators
Robin Robinson As the industry looks for new avenues to fill its pipeline, the incubator model provides speed, innovation, and results. In November 2013, Wellspring Biosciences discovered small molecules that bind irreversibly to a common oncogenic mutant, K-Ras G12C, one of the most promising ap...
By PharmaVoice Team • Dec. 28, 2013 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Pharma Pool Greg Barrett Dr. Glenn Gormley Daiichi Sankyo Makes Two New Executive Appointments Greg Barrett has been appointed as the new acting head of the Commercial Division of Daiichi Sankyo. He holds the new title of acting president, Daiichi Sankyo Administrative & Commercia...
By Ann Grey • Dec. 28, 2013 -
PharmaVoice Team/PharmaVoice
On the Calendar
The Calendar The 13th annual ePharma conference, Feb. 10-12, New?York Marriott Marquis, brings three days of strategic and tactical learning, peer exchange, and dialogue that actively dissects current trends, marketplace needs, evolving customer bases, and explains how to harness these new opport...
By PharmaVoice Team • Dec. 28, 2013 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, Marketing, and R&D?Trends Affecting the Healthcare Industry U.S. Mobile Health Audience Jumps Trending Now: Having mobile-optimized websites is key in light of the growth of mobile health The number of Americans using mobile phones for health information or tools reached 95...
By Denise Myshko • Dec. 28, 2013 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Deloitte Launches Real-World Evidence Platform Trending Now: Data analytics can provide insights and relationships among drugs and diseases across broad patient populations over time. Deloitte has released PopulationMiner, a real-...
By Denise Myshko • Dec. 28, 2013 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Cooney/Waters and Russo Partners Launch New Agency Trending Now: Integrated communications service provides healthcare companies with support throughout their business and product lifecycles. Cooney/Waters and Russo Partners has launched Cl...
By Ann Grey • Dec. 28, 2013 -
PharmaVoice Team/PharmaVoice
eSolutions: A Custom Fit
eSolutions: A Custom Fit A collaborative approach to building a program mixed with superior customer support will yield more efficient data collection and management, and in return the sponsor will be more inclined to work with that vendor again. Patient reported outcomes, patient data capture, ...
By Doug Liberi • Nov. 13, 2013 -
PharmaVoice Team/PharmaVoice
Save Time, Money and Eliminate Redundancy with InvestigatorSpace, Enterprise Investigator Portal
Save Time, Money and Eliminate Redundancy with InvestigatorSpace, Enterprise Investigator Portal For nearly a decade, Trifecta has been on the forefront of innovation in Investigator portals. The company perfected a host of solutions that make Investigator training and related site start-up proce...
By Dave Young • Nov. 13, 2013 -
PharmaVoice Team/PharmaVoice
Moving Clinical Trials to the Cloud: A New Paradigm to Transform Clinical Trials
Moving Clinical Trials to the Cloud A New Paradigm to Transform Clinical Trials Clinical trial sponsors are facing intense pressures to change the way clinical research is conducted in order to decrease costs and speed up the R&D process. This will bring new treatments to market sooner and ad...
By Raj Indupuri • Nov. 13, 2013 -
PharmaVoice Team/PharmaVoice
How to Solve Your Patient Retention and Compliance Problems with Patient Reminders
How to Solve Your Patient Retention and Compliance Problems with Patient Reminders Patient compliance and retention are critical to the success of your clinical trial. Anyone who has helped recover a noncompliant study or reduce the volume of early patient withdrawal knows the recovery process is...
By Mark Taggart • Nov. 13, 2013
Previous
